Fatty acid-binding protein3 expression in BeWo cells, a human placental choriocarcinoma cell line

Prostaglandins Leukot Essent Fatty Acids. 2017 May:120:1-7. doi: 10.1016/j.plefa.2017.04.002. Epub 2017 Apr 5.

Abstract

Cellular uptake of long chain fatty acids in human placental trophoblasts is thought to be mediated by several membrane- and cytoplasmic fatty acid-binding proteins (FABP). FABP3 was shown to be involved in long chain polyunsaturated fatty acids (LCPUFA) uptake in human trophoblastic choriocarcinoma cells, BeWo as the uptake of arachidonic acid,20:4n-6 (ARA) was decreased in FABP3-knockdown BeWo cells. However, the regulation of expression of FABP3 in these cells is not yet well known. The aim of the present study was to examine the FABP3 expression by LCPUFAs, insulin and LXR agonists in BeWo cells. Among all these fatty acids tested, only ARA dose-dependently stimulated the expression of FABP3 protein in these cells after 24h incubation while other fatty acids had no such effect. In addition, LXR agonist and insulin dose-dependently increased FABP3 protein expression in these cells after 24h incubation. Insulin-stimulated FABP3 protein expression was accompanied with an increased arachidonic acid uptake. Differentiated BeWo cells had lesser expression of FABP3 protein than in the undifferentiated cells as the cellular differentiation state was measured by hCG production. In preeclamptic placental tissue, lowered expression of FABP3 protein was observed compared with those in normal pregnancy. All these data indicate that FABP3 may in be part involved in ARA uptake in these cells and its expression may be regulated by ARA, insulin, LXR and the state of cellular differentiation.

Keywords: ARA; BeWo; DHA; FABP3; Insulin; LXR; Trophoblast cells.

MeSH terms

  • Arachidonic Acid / pharmacology
  • Cell Differentiation / drug effects
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Enzyme-Linked Immunosorbent Assay
  • Fatty Acid Binding Protein 3 / metabolism*
  • Fatty Acids / pharmacology
  • Female
  • Humans
  • In Vitro Techniques
  • Insulin / pharmacology
  • Liver X Receptors / agonists
  • Liver X Receptors / metabolism
  • Oleic Acid / pharmacology
  • Palmitic Acid / pharmacology
  • Placenta / drug effects
  • Placenta / metabolism*
  • Pregnancy
  • RNA, Messenger / metabolism
  • alpha-Linolenic Acid / pharmacology

Substances

  • FABP3 protein, human
  • Fatty Acid Binding Protein 3
  • Fatty Acids
  • Insulin
  • Liver X Receptors
  • RNA, Messenger
  • alpha-Linolenic Acid
  • Arachidonic Acid
  • Oleic Acid
  • Palmitic Acid